$Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)$

Impaired active relaxation during dynamic exercise in patients with heart failure with a preserved ejection fraction (HfpEF)

Bibliografski detalji
Glavni autori:	Phan, T, Nallur-Shivu, G, Abozguia, K, Mahadevan, G, Ahmed, I, Anderson, S, Williams, L, Nassimizadeh, M, Clarke, K, Frenneaux, M
Format:	Journal article
Izdano:	2008

Slični predmeti

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
od: Ajmer Singh, i dr.
Izdano: (2018-01-01)

Tubulin expression and modification in heart failure with preserved ejection fraction (HFpEF)
od: Lisa Schulz, i dr.
Izdano: (2022-09-01)

Proteomic and phosphoproteomic profiling in heart failure with preserved ejection fraction (HFpEF)
od: María Valero-Muñoz, i dr.
Izdano: (2022-08-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): A Case Report
od: Amanda Halimi, i dr.
Izdano: (2021-09-01)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
od: M. A. Manukyan, i dr.
Izdano: (2021-11-01)

Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
od: Masami Nishino, i dr.
Izdano: (2021-06-01)

Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency.
od: Phan, T, i dr.
Izdano: (2009)

Focus on HFpEF in heart failure
od: Chunhui He, i dr.
Izdano: (2022-05-01)

Similarities and Differences Between HFmrEF and HFpEF
od: Peixin Li, i dr.
Izdano: (2021-09-01)

Predictors and Mortality for Worsening Left Ventricular Ejection Fraction in Patients With HFpEF
od: Liling Chen, i dr.
Izdano: (2022-02-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 3 Devices Based Treatment and Commentary
od: Soneil Guptha , Eteri Tsetskhladze
Izdano: (2024-08-01)

Enhanced central sympathetic tone induces heart failure with preserved ejection fraction (HFpEF) in rats
od: Shyam S. Nandi, i dr.
Izdano: (2023-12-01)

Stratified Treatment of Heart Failure with preserved Ejection Fraction: rationale and design of the STADIA‐HFpEF trial
od: Mariëlle Scheffer, i dr.
Izdano: (2020-12-01)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
od: Dzhioeva O, i dr.
Izdano: (2020-08-01)

The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
od: Shenghua Zhou, i dr.
Izdano: (2025-03-01)

Heart failure with preserved ejection fraction (HFpEF) pathophysiology study (IDENTIFY-HF): does increased arterial stiffness associate with HFpEF, in addition to ageing and vascular effects of comorbidities? Rationale and design
od: Prithwish Banerjee, i dr.
Izdano: (2019-11-01)

The Oxygen Cascade According to HFpEF Likelihood
od: Jan Verwerft, MD, i dr.
Izdano: (2024-07-01)

Carnitine is a friend in HFpEF and foe in HFrEF
od: Huiqing Wang, i dr.
Izdano: (2024-10-01)

Locomotor and respiratory muscle abnormalities in HFrEF and HFpEF
od: Norman Mangner, i dr.
Izdano: (2023-10-01)

Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients
od: Leonie Grossekettler, i dr.
Izdano: (2020-05-01)

Arterial Stiffness Is an Important Predictor of Heart Failure with Preserved Ejection Fraction (HFpEF)—The Effects of Phosphate Retention
od: Yuji Mizuno, i dr.
Izdano: (2024-05-01)

Accelerometer vs. other activity measures in heart failure with preserved ejection fraction: the VITALITY‐HFpEF trial
od: Javed Butler, i dr.
Izdano: (2024-02-01)

Loeffler Endocarditis Causing Heart Failure with Preserved Ejection Fraction (HFpEF): Characteristic Images and Diagnostic Pathway
od: Silvia Lupu, i dr.
Izdano: (2022-09-01)

Diabetes Is the Strongest Predictor of Limited Exercise Capacity in Chronic Heart Failure and Preserved Ejection Fraction (HFpEF)
od: Venera Berisha-Muharremi, i dr.
Izdano: (2022-05-01)

Left atrial conduit flow rate at baseline and during exercise: an index of impaired relaxation in HFpEF patients
od: Paolo N. Marino, i dr.
Izdano: (2021-10-01)

Diet-Induced Obesity HFpEF Murine Models
od: Salvatore Carbone, PhD, MS, i dr.
Izdano: (2018-02-01)

Editorial: HFpEF and HFmrEF: Different Sides of the Same Coin?
od: Manuel Martínez-Sellés, i dr.
Izdano: (2022-05-01)

Different determinants of exercise capacity in HFpEF compared to HFrEF
od: Arlind Batalli, i dr.
Izdano: (2017-04-01)

Prognostic significance of dipstick proteinuria in heart failure with preserved ejection fraction: insight from the PURSUIT-HFpEF registry
od: Tetsuhisa Kitamura, i dr.
Izdano: (2021-09-01)

Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
od: Ruxin Wang, i dr.
Izdano: (2022-10-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 1 Review of Experience and Evidence in PARAGON-HF with Commentary
od: Soneil Guptha; Eteri Tsetskhladze
Izdano: (2023-07-01)

Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF)
od: Peter Luedike, i dr.
Izdano: (2018-05-01)

Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study
od: Ravi B. Patel, i dr.
Izdano: (2021-03-01)

Epicardial adipose tissue and exercise intolerance in HFpEF
od: Michelle Lobeek, i dr.
Izdano: (2024-10-01)

HFpEF as systemic disease, insight from a diagnostic prediction model reminiscent of systemic inflammation and organ interaction in HFpEF patients
od: Rong Zhou, i dr.
Izdano: (2024-03-01)

Characteristics, prognosis, and treatment response in HFpEF patients with high vs. normal ejection fraction
od: Jun Gu, i dr.
Izdano: (2022-09-01)

Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
od: Sören J. Backhaus, i dr.
Izdano: (2022-12-01)

Prevalence of Prediabetes and Newly diagnosed Diabetes in Patients with HFpEF and HFrEF
od: Ahmad ELSharawy, i dr.
Izdano: (2024-01-01)

Heart Failure with Preserved Ejection Fraction (HFpEF): Part 2 Review of Experience and Evidence with SGLT-2 Inhibitors and Commentary
od: Soneil Guptha, Eteri Tsetskhladze
Izdano: (2023-06-01)

Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction—A Specific HFpEF Phenotype
od: Ahmed Elsanhoury, i dr.
Izdano: (2021-09-01)